Healthcare provider profile · identity verified

Lance Fuchs, MD

Family Practice · SAN DIEGO, CA · NPI 1679612378

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	533	174
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	217	31
Amlodipine Besylate	Amlodipine Besylate	195	65
Lisinopril	Lisinopril	175	59
Gabapentin	Gabapentin	166	59
Metformin Hcl	Metformin Hcl	158	50
Losartan Potassium	Losartan Potassium	156	50
Rosuvastatin Calcium	Rosuvastatin Calcium	149	48
Levothyroxine Sodium	Levothyroxine Sodium	133	40
Omeprazole	Omeprazole	132	52
Terazosin Hcl	Terazosin Hcl	116	34
Alendronate Sodium	Alendronate Sodium	110	33
Trazodone Hcl	Trazodone Hcl	106	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	90	25
Hydrochlorothiazide	Hydrochlorothiazide	89	33
Atenolol	Atenolol	87	26
Meloxicam	Meloxicam	80	33
Sertraline Hcl	Sertraline Hcl	79	28
Finasteride	Finasteride	72	24
Jardiance	Empagliflozin	72	23
Glipizide	Glipizide	69	19
Furosemide	Furosemide	66	25
Metoprolol Tartrate	Metoprolol Tartrate	65	24
Morphine Sulfate Er	Morphine Sulfate	65	suppressed
Simvastatin	Simvastatin	65	20
Tamsulosin Hcl	Tamsulosin Hcl	64	24
Albuterol Sulfate Hfa	Albuterol Sulfate	61	30
Bisoprolol Fumarate	Bisoprolol Fumarate	61	22
Famotidine	Famotidine	59	23
Potassium Chloride	Potassium Chloride	57	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	16
Ezetimibe	Ezetimibe	49	14
Hydralazine Hcl	Hydralazine Hcl	43	14
Pradaxa	Dabigatran Etexilate Mesylate	40	14
Lorazepam	Lorazepam	38	suppressed
Topiramate	Topiramate	37	suppressed
Propranolol Hcl	Propranolol Hcl	35	13
Tramadol Hcl	Tramadol Hcl	35	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	11
Fenofibrate	Fenofibrate	34	suppressed
Humulin N	Insulin Nph Human Isophane	31	11
Ibandronate Sodium	Ibandronate Sodium	28	suppressed
Alvesco	Ciclesonide	27	12
Allopurinol	Allopurinol	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Humulin R	Insulin Regular, Human	26	suppressed
Carvedilol	Carvedilol	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	25	11
Triamcinolone Acetonide	Triamcinolone Acetonide	25	15
Estradiol	Estradiol	24	12
Eliquis	Apixaban	23	suppressed
Hydrocortisone	Hydrocortisone	23	12
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Fluocinonide	Fluocinonide	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Cefadroxil	Cefadroxil	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Ozempic	Semaglutide	14	suppressed
Testosterone	Testosterone	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	13
Ibuprofen	Ibuprofen	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Metoprolol Succinate	Metoprolol Succinate	13	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	12	12
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Liraglutide	Liraglutide	12	suppressed
Prednisone	Prednisone	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error